| Page 1590 | Kisaco Research
 

Tony Ho

Executive Vice President – Head of Research and Development
CRISPR Therapeutics

Tony Ho

Executive Vice President – Head of Research and Development
CRISPR Therapeutics

Tony Ho

Executive Vice President – Head of Research and Development
CRISPR Therapeutics
 

Eytan Breman

R&D Director
Celyad Oncology

Eytan Breman

R&D Director
Celyad Oncology

Eytan Breman

R&D Director
Celyad Oncology
 

Frank Thielmann

Director of Operational Excellence
Takeda

Frank Thielmann

Director of Operational Excellence
Takeda

Frank Thielmann

Director of Operational Excellence
Takeda
 

James Patterson

Founder
Auxolytic

James Patterson

Founder
Auxolytic

James Patterson

Founder
Auxolytic
 

Blake Aftab

VP Preclinical and Translational Sciences
Atara Biotherapeutics

Blake Aftab

VP Preclinical and Translational Sciences
Atara Biotherapeutics

Blake Aftab

VP Preclinical and Translational Sciences
Atara Biotherapeutics
 

Nick Huntington

Co-Founder and CSO
oNKo Innate

Nick Huntington

Co-Founder and CSO
oNKo Innate

Nick Huntington

Co-Founder and CSO
oNKo Innate
 

Evren Alici

CEO
Vycellix

Evren Alici

CEO
Vycellix

Evren Alici

CEO
Vycellix
 

John Rossi

Senior Director
Kite Pharma

John Rossi

Senior Director
Kite Pharma

John Rossi

Senior Director
Kite Pharma
 

Dan Kaufman

Professor of Medicine – Division of Regenerative Medicine
UCSD

Dan Kaufman

Professor of Medicine – Division of Regenerative Medicine
UCSD

Dan Kaufman

Professor of Medicine – Division of Regenerative Medicine
UCSD
 

Jason Litten

CMO
Artiva

Jason Litten

CMO
Artiva

Jason Litten

CMO
Artiva